Rege Nephro Co Ltd: Valuation, Funding & Investors
Rege Nephro Co., Ltd. is a South Korean company specializing in the development of regenerative treatments for kidney diseases. The company is advancing clinical trials for RN-014, a promising treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD), and preparing for U.S. clinical trials. Additionally, Rege Nephro is completing preclinical trials for RN-032, a cell therapy product targeting Chronic Kidney Disease (CKD).
Leadership & Board
- Current Number of Employees
- 16
- Current LinkedIn Followers
- 366
Latest Estimated Valuation
- Total Amount Raised
- $15M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $15M
- Latest Funding Round
- Series B
Company Momentum
PositiveRege Nephro Co Ltd LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Rege Nephro Co Ltd had 16 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Rege Nephro Co Ltd had 366 followers as of November 9, 2026. The number of followers increased by 7 (1.95%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series B | $15.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| DCI Partners Co., Ltd. | Series B |
| JIC Venture Growth Investments Co., Ltd. | Series B |
| Nippon Venture Capital CO., Ltd. | Series B |
| TOHOKU University Venture Partners Co., Ltd. | Series B |
| Golden Asia Fund Ventures Ltd. | Series B |
| Mitsui Chemicals, Inc. | Series B |
| Global Brain Corporation | Series B |
| Kyoto University Innovation Capital Co., Ltd. | Series B |
Similar Companies
A snapshot of private companies similar to Rege Nephro Co Ltd, helping you discover and navigate related company profiles.
Related News and Analysis
